Recombinant Human tPA/PLAT Protein (His Tag)
| Specifications | |
|---|---|
| Molecular Weight: | 61.7 kDa |
| Tag: | C-6His |
| Source: | Human Cells |
| Purity: | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin Level: | < 1.0 EU per µg as determined by the LAL method. |
| Format: | Lyophilized from a 0.2 μm filtered solution of 20mM MES,150mM NaCl,0.2mM GaCl2,pH5.5. |
| Additional Information | |
|---|---|
| Synonyms: | T-PA; TPA; t-plasminogen activator; Tissue plasminogen activator; |
| Organism: | Human |
| Accn. No.: | P00750 |
Sequence Information
Ser36-Pro562
Background
Tissue-type plasminogen activator (PLAT) is a protein that secreted into extracellular space. PLAT contains five domains: EGF-like domain, fibronectin type-I domain, 2 kringle domains and peptidase S1 domain. It belongs to the peptidase S1 family. The main function of this protein is to convert plasminogen into biologically active plasmin. As a protease, PLAT plays a crucial role in regulating blood fibrinolysis, maintaining the homeostasis of extracellular matrix and in modulating the post-translational activation of growth factors. PLAT is found not only in the blood, where its primary function is as a thrombolytic enzyme, but also in the central nervous system (CNS). It participates in a number of physiological and pathological events in the CNS, as well as the role of neuroserpin as the natural regulator of PLAT's activity in these processes. Increased or decreased activity of PLAT leads to hyperfibrinolysis or hypofibrinolysis, respectively. In addition, as a cytokine, PLAT plays a pivotal role in the pathogenesis of renal interstitial fibrosis through diverse mechanisms. Thus, as a fibrogenic cytokine, it promotes the progression of kidney diseases.
Price
194,00 €
